enVVeno Medical

Quarterly Financials

Values in thousands 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Revenue
$812
$0
$0
$0
Gross Profit
406
-129
-136
-141
EBITDA
-6,577
-6,041
-5,318
-5,362
EBIT
-6,699
-6,170
-5,454
-5,503
Net Income
-6,229
-5,642
-4,956
-4,992
Net Change In Cash
812
0
0
0
Free Cash Flow
-5,109
-4,285
-3,922
-3,559
Cash
1,754
17,915
2,380
2,314
Basic Shares
17,142
16,067
16,067
16,056

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$0
$0
$0
$0
Gross Profit
-546
-525
-452
EBITDA
-23,826
-25,018
-24,509
-16,753
EBIT
-25,238
-25,034
-17,205
Net Income
-21,819
-23,516
-24,304
-16,196
Net Change In Cash
0
0
0
0
Cost of Revenue
-50,173
Free Cash Flow
-16,875
-18,891
-15,734
-12,213
Cash
1,754
3,620
4,555
54,727
Basic Shares
17,142
12,301
11,230
8,679

Earnings Calls

Quarter EPS
2024-12-31
-$0.30
2024-09-30
-$0.35
2024-06-30
-$0.31
2024-03-31
-$0.31